SWK Holdings Corporation (SWKH)

USD 16.15

(-2.42%)

Market Cap (In USD)

197.56 Million

Revenue (In USD)

37.76 Million

Net Income (In USD)

15.88 Million

Avg. Volume

13.28 Thousand

Currency
USD
Country
Financial Services
Open
-
Prev. Close
-
Day Range
-
Year Range
15.14-18.49
PE
-
EPS
-
Beta Value
0.364
ISIN
US78501P2039
CUSIP
78501P203
CIK
1089907
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Financial Services
Industry
Asset Management
CEO
Mr. Jody. D Staggs
Employee Count
-
Website
https://www.swkhold.com
Ipo Date
1999-09-23
Details
SWK Holdings Corporation, a specialty finance company that focuses on the healthcare sector. It operates in two segments, Finance Receivables and Pharmaceutical Development. The company provides customized financing solutions to a range of life science companies, including companies in the biotechnology, medical device, medical diagnostics and related tools, animal health, and pharmaceutical industries, as well as institutions and inventors. It also offers non-discretionary investment advisory services to institutional clients in separately managed accounts to invest in life science finance. In addition, the company engages in the pharmaceutical development, formulation and manufacturing, and licensing business through the Peptelligence platform. Further, it intends to out-license its internal product pipeline to create novel formulations using its proprietary technology to develop treatments for patients and caregivers. The company was formerly known as Kana Software, Inc. and changed its name to SWK Holdings Corporation in December 2009. SWK Holdings Corporation was founded in 1996 and is headquartered in Dallas, Texas.

More Stocks